Literature DB >> 15589813

Reference values for cardiac troponins T and I in healthy neonates.

Hannsjörg Baum1, Anika Hinze, Peter Bartels, Dieter Neumeier.   

Abstract

OBJECTIVES: Cardiac troponins T (cTnT) and I (cTnI) are the most sensitive biochemical parameters in the detection of myocardial damage. In neonates, in utero exposure to tocolytic therapy results in detectable values of cardiac troponins after delivery. Additionally, some preliminary results suggest that the upper reference limits for healthy newborns are higher than those for adults but definitive reference limits for newborns are not available. Our objective was to determine those limits. DESIGN AND METHODS: In this study we investigated the distribution of cTnT and cTnI in cord blood of 869 healthy newborns. cTnT was determined with the 3rd generation assay and cTnI with the Dade Behring assay on a Dimension RxL. For data analysis Student's t test and the Mann-Whitney U test were used.
RESULTS: Using the 99th percentile, the upper reference limit in healthy termed newborns was 0.097 microg/l for cTnT and 0.183 microg/l for cTnI. Compared to the adult values, the newborn upper limit was tripled for cTnT and doubled for cTnI. Statistically significant differences were found between males and females for cTnT and between natural childbirth and caesarean section for cTnI.
CONCLUSION: Healthy-termed newborns have a higher upper reference limit for both cTnT and cTnI compared to adults. This circumstance must be taken into account when interpreting slightly "elevated" cTnT and cTnI values in newborns.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15589813     DOI: 10.1016/j.clinbiochem.2004.08.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

Review 1.  Myocardial Infarction in Neonates: A Review of an Entity with Significant Morbidity and Mortality.

Authors:  Koyelle Papneja; Anthony K Chan; Tapas K Mondal; Bosco Paes
Journal:  Pediatr Cardiol       Date:  2017-02-25       Impact factor: 1.655

2.  Cardiac troponin I, cardiac troponin-specific autoantibodies and natriuretic peptides in children with hypoplastic left heart syndrome.

Authors:  Anneli Eerola; Tuija Poutanen; Tanja Savukoski; Kim Pettersson; Heikki Sairanen; Eero Jokinen; Jaana Pihkala
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-10-06

Review 3.  Cardiac injury biomarkers in paediatric age: Are we there yet?

Authors:  Ana L Neves; Tiago Henriques-Coelho; Adelino Leite-Moreira; José C Areias
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

4.  Dynamic changes of high-sensitivity troponin T concentration during infancy: Clinical implications.

Authors:  P Jehlicka; D Rajdl; E Sladkova; A Sykorova; J Sykora
Journal:  Physiol Res       Date:  2021-01-14       Impact factor: 1.881

5.  Myocardial injury in infants ventilated on the paediatric intensive care unit: a case control study.

Authors:  Simon J Clark; Michael Eisenhut; Dorothea Sidaras; Stephen W Hancock; Paul Newland; Kent Thorburn
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  The Evaluation of Cardiac Troponin T in Newborns.

Authors:  Agata Tarkowska; Wanda Furmaga-Jabłońska
Journal:  Biomed Hub       Date:  2017-10-10

7.  Cardiac Troponin T in Healthy Full-Term Infants.

Authors:  Jonna Karlén; Mathias Karlsson; Håkan Eliasson; Anna-Karin Edstedt Bonamy; Cecilia Pegelow Halvorsen
Journal:  Pediatr Cardiol       Date:  2019-09-05       Impact factor: 1.655

8.  Myocardial performance assessment in neonates by one-segment strain and strain rate analysis by tissue Doppler - a quality improvement cohort study.

Authors:  Eirik Nestaas; Asbjørn Støylen; Drude Fugelseth
Journal:  BMJ Open       Date:  2012-08-24       Impact factor: 2.692

9.  Perinatal changes of cardiac troponin-I in normal and intrauterine growth-restricted pregnancies.

Authors:  Nicoletta Iacovidou; Maria Boutsikou; Demetrios Gourgiotis; Despina D Briana; Stavroula Baka; Venetia-Maria Vraila; Louiza Kontara; Demetrios Hassiakos; Ariadne Malamitsi-Puchner
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.